✦ LIBER ✦

Syndrome X causes nonalcoholic fatty liver disease (NADLD) in patients with hepatitis C (HCV) and increases the risk of cirrhosis

✍ Scribed by Melissa J. Contos; Richard K. Sterling; Velimir A. Luketic; Mitchell L. Shiffman; A.Scott Mills; Arun J. Sanyal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonalcoholic fatty liver disease in pati

✍ Arun J Sanyal; Melissa J Contos; Richard K Sterling; Velimir A Luketic; Mitchell 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

The Impact of Nonalcoholic Fatty Liver D

✍ A.L. Mindikoglu; A. Regev; P.Y. Casanova-Romero; P.A. Bejarano; E.J. Martinez; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

118 METABOLIC FATTY-LIVER DISEASE INCREA

✍ Pais, R.; Lebray, P.; Rousseau, G.; Rudler, M.; Thabut, D.; Charlotte, F.; Bonyh 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Genetic polymorphisms influencing insuli

✍ P. Dongiovanni; L. Valenti; R. Rametta; A.L. Fracanzani; S. Fargion 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The effect of etanercept on hepatic fibr

✍ A. Campanati, G. Ganzetti, A. Di Sario, A. Damiani… 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 264 KB

P1135 ADDITION OF TELAPREVIR OR BOCEPREV

✍ Londoño, M.-C.; Perelló, C.; Cabezas, J.; Carrión, J.-A.; Lens, S.; Mariño, Z.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 99 KB